Ivan Diamond

Dr. Diamond is Professor of Cellular and Molecular Pharmacology at University of California, San Francisco, and Founding Director at Ernest Gallo Clinic and Research Center. Dr. Diamond is a world-renowned GPCR expert and experienced in drug development for adenosine receptor inhibitors for Parkinson’s disease, addiction and prostate cancer. Dr. Diamond was Senior Advisor at Gilead Sciences. He received an M.D. and Ph.D. from the University of Chicago.